Bone Morphogenetic Protein-4 Mediates Cardiac Hypertrophy, Apoptosis, and Fibrosis in Experimentally Pathological Cardiac Hypertrophy-Reference-Cited by-同舟云学术

Bone Morphogenetic Protein-4 Mediates Cardiac Hypertrophy, Apoptosis, and Fibrosis in Experimentally Pathological Cardiac Hypertrophy

Published:2013-02 Issue:2 Volume:61 Page:352-360
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Sun Bo¹,Huo Rong¹,Sheng Yue¹,Li Yue¹,Xie Xin¹,Chen Chang¹,Liu Hui-Bin¹,Li Na¹,Li Cheng-Bo¹,Guo Wen-Ting¹,Zhu Jiu-Xin¹,Yang Bao-Feng¹,Dong De-Li¹

Affiliation:

1. From the Department of Pharmacology, the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education (B.S., R.H., Y.S., X.X., C.C., H.-B.L., N.L., C.-B.L., W.-T.G., J.-X.Z., B.-F.Y., D.-L.D.), and the Cardiovascular Department (Y.L.), Harbin Medical University, Harbin, P.R. China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference23 articles.

1. Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies

2. The role of bone morphogenetic proteins in vertebral development.;Monsoro-Burq AH;Development,1996

3. Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production From a Nox1-Based NADPH Oxidase

4. Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway

5. Bone Morphogenic Protein-4 Induces Hypertension in Mice

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of HIF2 leads to vascular remodeling and inflammation, coronary thrombosis and arterial dilation, recapitulating cardiac involvement of Kawasaki disease;2024-01-25

2. Lutein suppresses ferroptosis of cardiac microvascular endothelial cells via positive regulation of IRF in cardiac hypertrophy;European Journal of Pharmacology;2023-11

3. Myocardial Remodeling in Early Chronic Kidney Disease—Mineral and Bone Disorder Model with Low Bone Turnover;Kidney and Dialysis;2023-10-03

4. Plasma levels of bone morphogenic protein-4 are downregulated in elderly hypertensive patients with heart failure with preserved ejection fraction;Clinical Biochemistry;2023-06

5. Silicate Nanoplatelets Promotes Neuronal Differentiation of Neural Stem Cells and Restoration of Spinal Cord Injury;Advanced Healthcare Materials;2023-05-17